We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Liver Safety Concerns Prompt FDA Hold on Achillion Trial
Liver Safety Concerns Prompt FDA Hold on Achillion Trial
July 12, 2013
The FDA has put Achillion Pharmaceuticals’ hepatitis C drug sovaprevir on clinical hold after elevations in liver enzymes were found in healthy patients, the company said July 1.